Point72 Asset Management
ELOS

Point72 Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Point72 Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-60,000
Closed -$601K – 866
2014
Q3 		$601K Buy
+60,000
New +$610K ﹤0.01% 589

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Point72 Asset Management's ELOS Position: Q4 2014 in Review

Point72 Asset Management sold out of Syneron Medical Ltd (ELOS) in Q4 2014, closing a stake of 60,000 shares — an estimated $601K sold.

Point72 Asset Management first reported a position in ELOS in Q3 2014 and held it in 1 quarter. The position peaked at $601K in Q3 2014. 68 funds tracked by Wall St. Rank hold ELOS as of Q4 2014.

  • Point72 Asset Management reported no remaining Syneron Medical Ltd position as of Q4 2014 after selling out during the quarter.
  • Point72 Asset Management sold 60,000 Syneron Medical Ltd shares in Q4 2014, an estimated $601K.
  • Point72 Asset Management first reported a position in Syneron Medical Ltd in Q3 2014 and held it in 1 quarter.
  • Point72 Asset Management's Syneron Medical Ltd position peaked at $601K in Q3 2014.
  • 68 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2014.

Based on Point72 Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.